|
2005 Conference Publication Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL)Lane, S. W., Mollee, P. N., Bird, R., Porceddu, S. and Gill, D. (2005). Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL). 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, United States, 10-13 December 2005. Washington, DC, United States: American Society of Hematology. |
|
2005 Conference Publication A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphomaKuruvilla, J., Mollee, P., Song, K., Zaretsky, Y., Panzarella, T., McCrae, J., Nagy, T., Crump, M. and Keating, A. (2005). A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma. 9th International Conference on Malignant Lymphoma, Lugano, Switzerland, 9 -11 June 2005. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdi582 |
|
2004 Conference Publication Optimal timing of peripheral blood stem cell mobilisation in patients with hematological malignancies treated with the hyper-CVAD chemotherapy regimenMills, AK, Gibbs, S, Keane, C, Mollee, P, Grimmett, K, Van Kuilenburg, R, Saal, R, Gill, D, Prince, HM, Seymour, JF and Marlton, P (2004). Optimal timing of peripheral blood stem cell mobilisation in patients with hematological malignancies treated with the hyper-CVAD chemotherapy regimen. 46th Annual Meeting of the American-Society-of-Hematology, San Diego Ca, Dec 04-07, 2004. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2004 Conference Publication Serum free light chain ratios do not detect relapse in some patients with intact immunoglobulin myeloma post autologous peripheral blood stem cell transplantation.Tate, JR, Mollee, P and Gill, D (2004). Serum free light chain ratios do not detect relapse in some patients with intact immunoglobulin myeloma post autologous peripheral blood stem cell transplantation.. 56th Annual Meeting of the American-Association-for-Clinical-Chemistry, Los Angeles Ca, Jul 25-29, 2004. WASHINGTON: AMER ASSOC CLINICAL CHEMISTRY. |
|
2003 Conference Publication The impact of the hyper-CVAD chemotherapy regimen on the ability to mobilize peripheral blood stem cells (PBSC) in patients with hematological malignancies.Mollee, PN, Mills, AK, Grimmett, K, Van Kuilenburg, R, Saal, RJ, Gill, D, Cobcroft, R and Marlton, P (2003). The impact of the hyper-CVAD chemotherapy regimen on the ability to mobilize peripheral blood stem cells (PBSC) in patients with hematological malignancies.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego, CA, United States, 6-9 December 2003. Washington, DC, United States: American Society of Hematology. |
|
2002 Conference Publication Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL).Mollee, P, Song, K, Keating, A, Tsang, R and Crump, M (2002). Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL).. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, Dec 06-10, 2002. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2002 Conference Publication Effect of gemcitabine, dexamethasone and cisplatin salvage chemotherapy (GDP) on peripheral blood stem cell (PBSC) mobilization in patients with lymphoma.Mollee, P, Nagy, T, Saragosa, R, Turner, R, Keating, A and Crump, M (2002). Effect of gemcitabine, dexamethasone and cisplatin salvage chemotherapy (GDP) on peripheral blood stem cell (PBSC) mobilization in patients with lymphoma.. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, Dec 06-10, 2002. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2002 Conference Publication Long-term outcome following high-dose therapy with etoposide, melphalan, TBI and autologous stem cell transplantation (ASCT) for acute myeloid leukemia (AML).Mollee, P, Gupta, V, Song, K, Tsang, R, Crump, M and Keating, A (2002). Long-term outcome following high-dose therapy with etoposide, melphalan, TBI and autologous stem cell transplantation (ASCT) for acute myeloid leukemia (AML).. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, Dec 06-10, 2002. |
|
2002 Conference Publication Allogeneic stem cell transplantation for idiopathic myelofibrosis in AustralasiaDurrant, S, Szer, J, Bradstock, K, Nivison-Smith, I and Mollee, P (2002). Allogeneic stem cell transplantation for idiopathic myelofibrosis in Australasia. 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Canberra Australia, May 11-13, 2005. LONDON: NATURE PUBLISHING GROUP. |
|
2001 Conference Publication Prolonged engraftment and transgene expression of genetically modified autologous bone marrow stromal (mesenchymal) cells after infusion post autotransplant: A platform for cell and gene therapy.Keating, A, Filshie, R, Mollee, P and Wang, XH (2001). Prolonged engraftment and transgene expression of genetically modified autologous bone marrow stromal (mesenchymal) cells after infusion post autotransplant: A platform for cell and gene therapy.. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2001 Conference Publication Low dose valaciclovir for the prevention of CMV disease post allogeneic bone marrow transplantationIrving, I, Williamson, J, Mollee, P, Morton, AJ, Sloots, T, Siebert, D and Durrant, S (2001). Low dose valaciclovir for the prevention of CMV disease post allogeneic bone marrow transplantation. BASINGSTOKE: NATURE PUBLISHING GROUP. |
|
2001 Conference Publication Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.Durrant, S., Irving, I., Mollee, P., Morton, A. J., Webb, M. and Macfarlane, D. (2001). Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.. 27th Annual Meeting of the European Group for Blood and Marrow Transplantation, London, United Kingdom: Nature Publishing Group. |
|
2000 Conference Publication Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD.Mollee, P, Morton, J, Irving, I and Durrant, S (2000). Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD.. |
|
2000 Conference Publication A Phase II study of Interferon alpha and intermittent oral Cytarabine in the treatment of newly diagnosed Chronic Myeloid Leukaemia.Mollee, P., Taylor, K., Arthur, C., Wright, S., Rodwell, R. and Taylor, D. (2000). A Phase II study of Interferon alpha and intermittent oral Cytarabine in the treatment of newly diagnosed Chronic Myeloid Leukaemia.. Perth, July 2000. Sydney: Haematology Society of Australia and New Zealand. |
|
2000 Conference Publication A phase II study of interferon alpha (IFN) and intermittent oral cytarabine (YNK01) in the treatment of newly diagnosed chronic myeloid leukemia (CML)Mollee, P., Taylor, K., Arthur, C., Wright, S. and Morton, J. (2000). A phase II study of interferon alpha (IFN) and intermittent oral cytarabine (YNK01) in the treatment of newly diagnosed chronic myeloid leukemia (CML). 2nd Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, Perth, WA, 25-28 July 2000. Washington, D.C.: American Society of Hematology. |
